摘要
目的:探讨多种血清肿瘤标志物联合检测对原发性肝癌的诊断价值。方法:采集110例原发性肝癌和152例良性肝病(肝硬化和慢性肝炎)患者血液,用化学发光法测定AFP、CEA和CA199水平。结果:原发性肝癌患者血清中AFP、CEA和CA199水平分别为(60.6±80.5)μg/L、(22.2±13.9)μg/L、(47.2±28.3)U/L,明显高于良性肝病患者血清水平;原发性肝癌患者中AFP、CEA和CA199阳性率分别为74.6%、49.1%和45.5%,显著高于良性肝病患者;三者联合检测将原发性肝癌检测敏感率提升至92.7%。结论:联合检测可提高原发性肝癌诊断的敏感率,在原发性肝癌的筛查中有一定的应用价值。
Objective： To study the clinical value of combined detection of the serum levels of AFP,CEA and CA199 in primary liver cancers.Methods： Collecting the serum samples from 110 primary hepatic cancer patients and 152 benign liver disease patients（hepatic cirrhosis and chronic hepatitis）,the serum levels of AFP,CEA and CA199 were measured by chemiluminescence.Results： The levels of AFP,CEA and CA199 were（60.6 ± 80.5） μg/L,（22.2 ±13.9） μg/L and（47.2 ±28.3） U/L in primary liver cancer patients respectively,it was significantly higher than that in benign liver disease patients.The serum positive ratio of AFP,CEA and CA199 in primary liver cancer patients were 74.6%,49.1% and 45.6%,respectively,it was significantly higher than that in benign liver disease patients too.The sensitivity of combined detection of three kinds of tumor markers was 92.7%.Conclusion： The combined detection of AFP,CEA and CA199 can arise the diagnosis sensitivity of primary hepat-ic cancer,it has some value in screening primary hepatic cancers.
出处
《西北国防医学杂志》
CAS
2011年第4期276-277,共2页
Medical Journal of National Defending Forces in Northwest China
